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A 64-year-old man underwent MRCP for further examination of gallbladder stones and IPMN of branch-type (IPMN-Br) was
pointed out. Yearly MRCP had revealed the gradual increase of the cystic components, marked dilation of the main pancreatic
duct(MPD),andﬁllingdefectsintheMPD.Afterfollow-upforthreeyears,heunderwentpancreatoduodenectomy.Histologically,
the dilated MPD and connecting dilated branch ducts were ﬁlled with nodular growth of tumor cells consisting of gastric-type
adenoma with pyloric gland-like structures. In the MPD, a transition from gastric-type adenoma to intestinal-type carcinoma
was observed. In addition, in a dilated branch duct, some components of intestinal-type carcinoma with marked arborizing
structures were observed. A minimally invasion was observed around branch ducts. Immunohistochemistry revealed diﬀuse
nuclear accumulation of PCNA and Ki67 in the tumor cells of branch dusts. Our observations suggest that the secondary
inﬁltration to the MPD of IPMN-Br and IPMN-Br possesses malignant potential for microinvasion.
Copyright © 2009 Yuichi Sanada et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
The malignant potential of intraductal papillary-mucinous
neoplasm (IPMN) of the pancreas has been estimated based
on three viewpoints: histologic grades (adenoma, carcinoma
and their borderline lesion), localization (main duct-type
and branch duct-type), and histologic subtypes (gastric
type, intestinal type, pancreatobiliary type, and oncocytic
type) [1, 2]. These viewpoints have a deep connection for
each other, such as, the gastric type, which occurs in the
periphery of the pancreatic parenchyma, corresponds to the
branch duct type, and which usually shows a multicystic
lesionwithlessinvasive pattern,adenoma[2].Then,branch-
type IPMN (IPMN-Br) has been usually an object for just
follow up. However, recent guidelines indicated operative
indication as the followings: symptoms attributable to the
cyst, dilation of the main pancreatic duct (MPD) over
10mm, cyst size over 30mm with the intramural nodule, or
cystic ﬂuid with cytological malignancy [3]. In fact, relative
surgical indications were applied for cases with disease
development such as pancreatitis, positive cytology, or solid
mass formation in the followup term for IPMN-Br [4, 5].
By contrast, there was no report describing the IPMN-Br
to show morphologic change and transformation to the
main duct. In the present, our experienced IPMN-Br case,
which is visualized for transition gradually from branch to
MPD in three years followup images, was found to include
several patterns of subtypes by histopathological study. This
phenomenon might be critical to estimate the malignant
potential or surgical indication for IPMN-Br.
2.CaseReport
A continuous image of 64-year-old man, who was referred
to the Department of Medicine at our hospital for further
evaluation of gallbladder stones, was shown in Figure 1.
A magnetic resonance cholangiopancreatography (MRCP)
showed a multilocular cystic lesion for 20mm in diameter
in the head of the pancreas. The main pancreatic duct
was noted smoothly except for the head adjacent to the
multilocular cyst. Although these ﬁndings suggested a cystic
neoplasm such as serous cystadenoma, the existence of
duct-cyst connection (arrow) strongly suggested that the
most likely diagnosis was intraductal papillary-mucinous2 Journal of Oncology
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Figure 1: (a) MRCP in 2003. Cystic dilation of branch ducts is observed in the pancreas head (arrow). A duct-cyst junction is visible (yellow
arrowhead). (b) MRCP in 2004 shows the increasing of size and dilation of the main pancreatic duct. (c) MRCP in 2005. The boundary
between the main pancreatic duct and the cystic components of branch ducts disappears. (d) MRCP in 2006. Filling defects in the main
pancreatic duct are visible (arrow).
neoplasm (IPMN) mainly located in the branch ducts.
Followup MRCP revealed gradual increase of the cystic
componentsanditssizes,from2.0cmto3.8cmwithdilation
of MPD over 10mm until 2005. In 2006, since intraductal
nodule with elevation of serum amylase appeared, surgical
indication was evaluated. The levels of serum tumor marker,
such as carcinoembryonic antigen (CEA) or carcinohydrate
antigen 19-9 (CA19-9), were in normal range. The cyto-
logical study for pancreatic juice showed ﬁndings for high-
grade intraductal papillary-mucinous carcinoma (IPMC);
therefore, surgical procedure was selected. On laparotomy,
a cystic mass, 4.0cm in diameter, was identiﬁed in the pan-
creatic head. Distal pancreatic parenchyma showed marked
ﬁbrosis. Pancreatoduodenectomy with regional lymph nodes
dissection was performed. Transection of the pancreas was
performed on theneck of the pancreas. Intraoperative US
revealed no additional cystic mass in the residual pancreas.
The standard study for resected specimen was described
in Figure 2. Macroscopically, cystic dilation of MPD was
ﬁlled with soft papillary tumor producing mucin. And
solid tumor in MPD and communicating branch ducts was
visualized with diﬀerent components: gastric-type adenoma
showing closely packed tubular glands similar as pyloric
gland-like morphology and dark eosinophilic cells with
marked pseudostratiﬁcatied spindle nuclei for an intestinal-
type carcinoma. In branch ducts, components of intestinal-
type carcinoma showed irregular arborizing growth. Adja-
cent to the branch duct, a minimal invasion was observed as
a dilated mucouslake containing scanty cancer cells ﬂoating
in the abundant mucin, indicating mucinous carcinoma.
Under consideration for the invasive components existed
with the distance of less than 5mm [6], this growth pattern
was corresponded to minimal invasion. Each subtype was
conﬁrmed by mucin phenotype (Figure 3,r i g h tc o l u m n ) .
Schematic presentation of histologic distribution in the
present case is shown in Figure 3 (left column).
Toestimatethemalignantpotential,additionalimmuno-
histochemistry (IHC) was performed by using primary
antibodies as followed: Ki67 (clone MIB-1, Nichirei, 1:200),
proliferating cell nuclear antigen (clone PCNA, DakoCy-
tomation, 1:200), and c-Met (clone c-Met, Santa Cruz
Biotechnology Inc, 1:200), as described in previous report.
These molecules have been reported to be involved in the
earlyeventsofcarcinogenesis,formationofinsitucarcinomaJournal of Oncology 3
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Figure 2: (a) Resected specimens show marked dilation of the main pancreatic duct and papillary tumor (arrow) with cystic dilation of
branch ducts (arrowhead). (b) Representative section and histologic distribution of the tumor. The boundary between the main pancreatic
duct and a branch duct is visible (arrow). (c) Gastric-type adenoma is made up of columunar cells with basally-oriented nuclei, showing
closely packed glands with anastomosing pattern (d) Intestinal-type carcinoma shows marked pseudostratiﬁcation and nuclear atypia
showing villous conﬁguration (e) In a branch duct, intestinal-type carcinoma components with arborizing features are observed (f) A
minimally invasive lesion is observed adjacent to branch ducts. Floating tumor cells in the mucous lake is visible (I, arrow).
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Figure3:Aschematicpresentationofhistologicsubtypesinthepresentcase(a).AnimmunohistochemicalimageforMUC2attheboundary
between gastric-type adenoma and intestinal-type carcinoma. Only the intestinal-type carcinoma shows diﬀuse staining for MUC2 (b).4 Journal of Oncology
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Figure 4: Representative immunohistochemical images in several components of the present tumor.
inthestepwiseprogressionofIPMNandordinarypancreatic
ductal carcinoma. The expression of the three molecules
was independently evaluated by two investigators (Y S and
S K). Evaluation of the staining was determined based on
the following criteria. In Ki67 and PCNA, stained cells were
accounted for less than 10% regarding for negative (0), and
10% or more for positive with further classiﬁed 10% to 30%
(1+) and over 30% (2+). For c-Met, positivity was rated for
1+ or 2+ under 30% cut-oﬀ line, respectively. Representative
imagesandresultsforIHCareshowninFigure 4andTable 1.
Ki67 and PCNA were focally stained in the intestinal-type
carcinoma in the MPD. In branch ducts, intestinal-type
carcinoma components showed diﬀuse staining for Ki67 and
PCNA. In addition, PCNA was focally stained in gastric-type
adenoma components in branch ducts, but not in the MPD.
C-Met was diﬀusely expressed in the intestinal-type car-
cinoma, whereas gastric-type adenoma components showed
focal and thin staining both in the MPD and branch ducts.
The microscopic and immunohistochemical ﬁndings
indicated a diagnosis of combined type IPMC with minimal
invasion from branch duct. The pancreatic parenchyma
showed marked ﬁbrotic change. No lymph node metastasis
was identiﬁed. Although the nodular growth of IPMN cells
was observed adjacent to the resection margin of the MPD,
the epithelium of the MPD at the resection margin was lined
with normal epithelial cells. He is in good condition without
any recurrence sign for these 26 months.
3. Discussion
In common, the indication of surgical procedures for IPMN-
Br was accepted for the presence of symptom, solid mass
formation, or positive cytology, suggesting the mucinous
cystic neoplasm. Otherwise, followup regimens based on
clinical experiences have no strong evidence, according to
the past report, once a year evaluation for lesions fewer than
1 0m m ,6t o1 2m o n t h sf o r1 0t o2 0m m ,a n d3t o6m o n t h s
for over 20mm [7]. Despite IPMN-Br was known for less
invasive comparing to the main-duct type, its malignant
morphology was also demonstrated [4]. Taken together, the
malignant potential is developing up to the size. In fact,
carcinoma in situ or invasive carcinoma was detected in 22%
of resected IPMN-Br [5]. In the present case, the cystic mass
grew up gradually year by year and the size was 3.8mm at
the time of operation after 36 months followup. According
tothepastreportfor66conservativecases,11IPMN-BrwereJournal of Oncology 5
Table 1: Immunohistyochemical results in several components.
Protein Main G-ad Int-ca Branch G-ad Int-ca
Ki67 0 1+ 0 2+
PCNA 0 1+ 1+ 2+
c-Met 1+ 2+ 0+ 2+
G-ad: gastric-type adenoma; Int-ca: intestinal-type carcinoma.
decidedforsurgicalprocedureafteramedianfollow-upof41
months [4]; 9 of the 11 patients had malignancy, including 4
carcinoma in situ and 5 invasive carcinomas.
Waters et al. enhanced the critical role of MRCP for
followup to provide the favorite information of IPMN with
matching actual pathology [8]. In the present case also, the
connection of cystic components to the MPD was clearly
detected due to MRCP, and the cystic lesion was found
to change its feature to grow up to the MPD. However,
among our referring to the past reports, the gradual
inﬁltration from IPMN-Br to the MPD during follow-up
has not been described. The present case was found to
have two independent subtypes, gastric-type and intestinal-
type, supporting the recognition for IPMN to compose a
combination of over two subtypes [1]. Previously, we also
described another case of IPMN with gastric-type adenoma
and intestinal-type borderline lesion [9]. The gastric-type
adenoma of the IPMN is known to be localized just in
the peripheral branches without any malignant potential
[10, 11], supporting that the IPMN-Br has to be applied
for followup. Then, the ﬁrst MRCP oﬀered clinical imaging
course demonstrated no doubt for the present IPMN to
rise from the peripheral branch. On the other hand, in
the resected specimen, both gastric-type adenoma and
intestinal-type carcinoma were detected in both the MPD
and branch ducts, demonstrating the possibility for IPMN-
Br to change the malignant morphology. The present feature
isusuallynottypicalforordinarygastric-typeadenoma[12],
and the distribution or histologic features in branch ducts
of the present case diﬀer from generally believed consensus
in terms of the following viewpoints. First, some papillary
components in branch ducts included intestinal carcinoma.
Second, minimally invasion was observed adjacent to a
branch duct, not to the MPD. Findings in the present case
suggest that tumor cells in branch ducts possess malignant
potential leading carcinogenesis.
Recently Ban et al. reported a case of gastric-typed
IPMN-Br with focal nodular growth to progress intraductal
carcinoma of pancreatobiliary type [13]. The present case
might be included these rare situation.
Imaging features during follow-up support the idea that
intraductal tumor cells in the MPD can be recognized as a
later stage in the present case, harboring more malignant
potential than those in branch ducts. Intestinal-type carci-
noma in the MPD is derived from the continuous progres-
sionthat corresponds to the branch duct type showing low
histologic grade (adenoma).
To evaluate the further actions for malignant potential in
IPMN-Br, IHC study was selected additionally.
Ki67 and PCNA were found to show positivity ratio
increasing with increasing grade of atypism in IPMN [14,
15]. In the present case, the most diﬀuse staining positively
of Ki67 and PCNA was observed in the components of
intestinal-type carcinoma of the present IPMN in branch
duct, but not in the MPD (Table 1).
Taken together, the present tumor had intestinal type
with high-grade malignant potential in early stage. PCNA
was also indicated to promote the proliferation of pancreatic
ductal carcinoma with interaction of KIAA0101 and Ki67
and then play a critical role in the regulation of cell cycle
[16]. These results suggest that tumor components with
malignant potential in peripheral branch ducts develop the
proliferation and formation of invasive potency.
In addition, c-Met is well known as a receptor of
hepatocyte growth factor and is also associated with early
events of carcinogenesis in the pancreas [17]. And, the high
expression of c-Met was also found to involve in intestinal
metaplasia of the bile duct epithelium, meaning its relation
to the intestinal pathway during carcinogenesis [17]. Then,
c-Met expression was most diﬀusely noted in intestinal type
carcinoma regardless of its localization (the MPD or branch
ducts), suggesting that the intestinal pathway is associated
with the morphogenesis of IPMN progression in branch
ducts.
In conclusion, the present clinical, regular histological,
and immunohistochemical observations provided evidence
that the components in branch ducts also might possess
malignantpotentialleadinginvasivecarcinoma.FurtherIHC
study to reveal the malignant potential will lead the extend
strategy in the future.
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